Antiparasitic mebendazole (MBZ) effectively overcomes cisplatin resistance in human ovarian cancer cells by inhibiting multiple cancer-associated signaling pathways

Ovarian cancer is the third most common cancer and the second most common cause of gynecologic cancer death in women. Its routine clinical management includes surgical resection and systemic therapy with chemotherapeutics. While the first-line systemic therapy requires the combined use of platinum-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Linjuan, Zhao, Ling, Zhang, Jing, He, Fang, Wang, Hao, Liu, Qing, Shi, Deyao, Ni, Na, Wagstaff, William, Chen, Connie, Reid, Russell R., Haydon, Rex C., Luu, Hue H., Shen, Le, He, Tong-Chuan, Tang, Liangdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312413/
https://www.ncbi.nlm.nih.gov/pubmed/34232919
http://dx.doi.org/10.18632/aging.203232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312413/
https://www.ncbi.nlm.nih.gov/pubmed/34232919
http://dx.doi.org/10.18632/aging.203232

Ejemplares similares